Clinical Trials Directory

Trials / Terminated

TerminatedNCT06419478

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis

Exploring Early Postoperative Core Symptoms in Chinese Patients With Primary Liver Cancer: a Cross-sectional and Longitudinal Network Analysis

Status
Terminated
Phase
Study type
Observational
Enrollment
249 (actual)
Sponsor
Mengmeng Yuan · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Patients with primary liver cancer (PLC) experience a range of symptoms in the early postoperative period. Symptoms include cancer-related symptoms and adverse effects of treatment. Exploring the core symptoms and their dynamics in the early post-hepatectomy patients may help provide better symptom management programs. The purpose of this study was to identify the core symptoms in early post-hepatectomy patients and to explore the trajectory of their dynamics. During the period from March 2021 to September 2022, a total of 281 patients diagnosed with PLC and undergoing radical curative surgery were recruited from the hepatobiliary surgery departments of two hospitals in Eastern China, among whom 249 individuals (88.60%) agreed to participate in the study. A comprehensive symptom assessment was administered to the patients 1-2 days after surgery (T1) and 1-2 days before discharge (T2). Network analysis was used to identify core symptoms in early post-hepatectomy patients based on symptom severity.

Conditions

Interventions

TypeNameDescription
OTHERpostoperative symptomsObservational study, focusing solely on symptom surveys of patients.

Timeline

Start date
2021-03-01
Primary completion
2022-08-31
Completion
2022-09-01
First posted
2024-05-17
Last updated
2024-05-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06419478. Inclusion in this directory is not an endorsement.

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis (NCT06419478) · Clinical Trials Directory